Procavea Biotech raises €150K Pre-Seed round
27 December 2023· Zurich, Switzerland· health, biotech, protein_engineering, drug_delivery, b2b, deep_hardware
The funding will be used to develop Procavea Biotech's patent portfolio, further validate its platform for siRNA applications, and test its first drug candidates in vivo. This work is intended to bring the technology to a level of maturity to secure a first funding round.
Investors
LeadVenture Kick
Also participating
Kickfund
About Procavea Biotech
Stage
Pre-Seed
Headquarters
Zurich, Switzerland
Founded
2021
Team Size
1–5
Sectors
healthbiotechprotein_engineeringdrug_deliveryb2bdeep_hardware